2007
DOI: 10.1007/s00464-007-9734-6
|View full text |Cite
|
Sign up to set email alerts
|

Transoral access for endoscopic thyroid resection

Abstract: Endoscopic transoral thyroid resection is possible. It proved to be a safe procedure in living pigs and astonishingly easy to perform. The results may be helpful for thyroid resections in humans using a similar access, as suggested by the thyroidectomies in human cadavers preceding this study.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
167
0
16

Year Published

2010
2010
2018
2018

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 258 publications
(184 citation statements)
references
References 20 publications
(25 reference statements)
1
167
0
16
Order By: Relevance
“…However, with those techniques, the scars are still seen at the incision area. Recently, natural orifice transluminal endoscopic surgery (NOTES) of the thyroid has been developed (7,8). A benefit of this innovative thyroid technique is its excellent cosmetic outcome due to scarless surgery.…”
Section: Introductionmentioning
confidence: 99%
“…However, with those techniques, the scars are still seen at the incision area. Recently, natural orifice transluminal endoscopic surgery (NOTES) of the thyroid has been developed (7,8). A benefit of this innovative thyroid technique is its excellent cosmetic outcome due to scarless surgery.…”
Section: Introductionmentioning
confidence: 99%
“…The rapid development of endoscopic techniques and instruments has allowed surgeons to perform a thyroidectomy from a remote site, providing a scar-free outcome in the neck. Recently, natural orifice thyroid surgery has been developed due to its potential for surgery with scar-free results (10)(11)(12)(13). The enhanced refinement of this transoral thyroidectomy technique was well-established and described by Anuwong as the transoral endoscopic thyroidectomy vestibular approach (TOETVA) with excellent clinical results (14).…”
Section: Introductionmentioning
confidence: 99%
“…Indications for TOETVA are as follows: a predicted gland width on diagnostic imaging ≤10 cm; a thyroid volume outline of <45 mL or dominant nodule dimension of ≤50 mm; Bethesda category 3 or 4 lesions; primary papillary microcarcinoma without local or distant metastasis; patient request for optimal aesthetic results (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16). Exclusion criteria are as follows: patients unfit for Brief Report on Thyroid Surgery Monitored transoral endoscopic thyroidectomy via long monopolar stimulation probe general anesthesia; precedent radiation in the head, neck, or upper mediastinum; antecedent neck surgery; recurrent goiter; a gland volume of >45 mL or main nodule diameter of >50 mm; documentation of lymph node or distant metastases, tracheal/esophageal infiltration, preoperative laryngeal nerve palsy, hyperthyroidism, mediastinal goiter, or oral abscesses.…”
Section: Patient Selection and Workupmentioning
confidence: 99%